Government Medical College and Hospital
ORCID: 0000-0003-2856-1371Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results”.
Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more
Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more
Noah J. Daniels, Filomena Pirozzi, Anthony Wynshaw‐Boris, Rodrigo Lopez-Gonzalez, Richard A. Padgett +1 more
Maria L. Habean, Nikhil Panicker, Jagjit Singh